Real-world Dapagliflozin Experience in Patients With Heart Failure in Greece
Clinical trial NCT05635331 · COMPLETED
Trial details
- NCT number
- NCT05635331
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-12-28
- Primary completion
- 2024-12-03
- Enrollment
- 257
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.